Apr 15 |
Acorda Therapeutics Announces Delisting from Nasdaq
|
Apr 6 |
Riskiest Junk Bonds Shunned in Europe on Rising Risk of Default
|
Apr 3 |
Acorda Therapeutics announces Nasdaq delisting notification
|
Apr 3 |
Acorda Therapeutics Announces Nasdaq Delisting Notification
|
Apr 3 |
Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
|
Apr 2 |
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Apr 2 |
Acorda files for bankruptcy, reveals asset sale plan
|
Apr 2 |
Acorda falls 59% as it files for Chapter 11 bankruptcy
|
Apr 1 |
Acorda Therapeutics and Merz Announce Signing of "Stalking Horse" Asset Purchase Agreement
|
Apr 1 |
Acorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024
|